PFAS Contamination in Botanical Raw Materials: What Midwest Supplement Brands Need to Know

Something changed in April 2024, and a lot of supplement brands weren’t paying attention.

The U.S. Environmental Protection Agency finalized its first-ever maximum contaminant levels (MCLs) for PFAS in drinking water — setting enforceable limits for PFOA and PFOS at 4 parts per trillion (ppt). For perspective, 4 ppt is roughly four drops dissolved in 250 million gallons of water. The analytical precision required to detect concentrations at that level is extraordinary. And the regulatory pressure it signals for the dietary supplement industry is not going away.

PFAS — per- and polyfluoroalkyl substances — are a family of more than 12,000 synthetic compounds that don’t break down in the environment or in living tissue. They’ve been in commercial use since the 1940s: non-stick coatings, firefighting foam, food packaging liners, water-resistant fabrics. They accumulate in soil, surface water, groundwater, and the bodies of people and animals that come into contact with them. They’re in the air near manufacturing sites. They’re in the biosolids that municipalities have been spreading on agricultural land for decades.

And increasingly, they’re turning up in botanical raw materials.

Why Botanical Ingredients Are Particularly Vulnerable

Plants absorb PFAS through their root systems. This isn’t speculative — it’s documented extensively in peer-reviewed literature, including studies published in Environmental Science & Technology and Journal of Hazardous Materials. Leafy plants and root vegetables concentrate PFAS more readily than grain crops, and several widely used botanicals (ashwagandha, echinacea, nettle leaf, dandelion root, valerian) fall squarely into those categories.

The contamination pathway that matters most for Midwest brands is agricultural biosolids. Municipalities across the country have applied treated sewage sludge — now marketed as “biosolids” — to farmland as fertilizer for decades. It’s legal under current federal rules, it’s common, and it’s a major PFAS vector. EPA data suggests that more than 50% of biosolids generated in the U.S. are land-applied. A significant share of that application has historically occurred in Illinois, Indiana, and Wisconsin — the same states where domestic botanical suppliers operate.

There’s a secondary contamination route that’s easier to overlook: raw material packaging and processing equipment. Certain fluorinated containers, PTFE-lined seals, and fluoropolymer-coated processing surfaces can leach PFAS into product over time, particularly when the material has elevated moisture content or acidity. Our team has seen this contribute meaningfully to detected PFAS concentrations in botanical extract testing — it doesn’t get discussed much, but it’s real.

The bottom line is this: your supplier’s CoA covers moisture content, maybe heavy metals, and (hopefully) identity. A PFAS panel is almost certainly not on it.

What Analytical Testing Laboratories Actually Measure

A PFAS screen in food and botanical matrices typically covers a panel of 40 to 70 individual compounds. The most toxicologically significant ones regulators focus on include PFOA, PFOS, PFBS, PFHxA, PFHxS, PFNA, and PFDA — but a comprehensive panel reaches well beyond those. The analytical gold standard is LC-MS/MS (liquid chromatography with tandem mass spectrometry), which reliably detects PFAS at sub-ppt concentrations even in complex botanical matrices.

For water, EPA Methods 533 and 537.1 are well-established. For food and supplement applications, ISO 21675 provides a validated framework, and many ISO 17025-accredited analytical testing laboratories have developed validated in-house methods modeled on FDA’s Total Diet Study work. The analytical challenge is matrix complexity: botanical extracts are dense with pigments, polyphenols, flavonoids, and other compounds that require careful sample preparation to isolate PFAS cleanly without instrument interference.

Turnaround times at accredited labs typically run 7–14 business days for a full PFAS panel, depending on workload and matrix complexity. Cost per sample has come down substantially as testing volume has scaled industry-wide — from roughly $400–600 a few years ago to around $200–350 today for a standard 40-compound panel. That’s not cheap, but it’s not prohibitive relative to what a single recall or retailer rejection costs.

One benchmark worth memorizing: the European Food Safety Authority (EFSA) established a tolerable weekly intake (TWI) for a mixture of four PFAS (PFOA, PFOS, PFNA, and PFHxS) of just 4.4 nanograms per kilogram body weight per week. That number is extremely conservative — and given how consistently the EU’s food safety thresholds foreshadow eventual FDA positions, brands positioning for European market access or domestic premium retail channels should treat it as directionally relevant right now.

The Regulatory Gap — and Why It’s Your Liability

Here’s the part that frustrates quality professionals: there are currently no FDA-established MCLs or action levels for PFAS specifically in dietary supplements. The agency has conducted PFAS monitoring through its Total Diet Study program and issued informational reports, but supplement-specific enforceable limits have not been published as of mid-2026.

Some brands read that gap as “we don’t have to test.” That reasoning won’t survive an FDA inspection.

Under 21 CFR Part 111 — the GMP regulations governing dietary supplement manufacturing — manufacturers are responsible for establishing specifications for the identity, purity, strength, and composition of their raw materials and finished products. The word “purity” carries a lot of weight. An FDA investigator can legitimately ask what steps you took to evaluate PFAS risk in your supply chain, particularly if a consumer complaint, import alert, or third-party testing result draws scrutiny to your brand.

Beyond federal regulatory risk, state-level pressure is already concrete. California, Michigan, and Massachusetts have passed or introduced PFAS-related consumer product legislation. If you’re selling into those markets — and most Midwest supplement brands are — state exposure is real even when FDA hasn’t acted at the federal level.

Retailers are moving faster than regulators, too. We’ve seen purchase specifications from regional and national retail buyers that include PFAS testing data or “PFAS-free” certification requirements as a condition of purchase. That’s not a legal mandate; it’s market reality, and it’s arriving faster than most compliance teams expected.

Building a Risk-Stratified PFAS Testing Protocol

You don’t need to test every lot of every ingredient at full PFAS panel frequency. What you need is a defensible, risk-based approach that you’ve documented and can explain.

Start with an exposure map. Identify which of your botanical raw materials are sourced domestically versus internationally. Domestic botanicals — particularly those grown in the upper Midwest — carry higher PFAS risk given documented biosolid application history in this region. Wildcrafted herbs present different and often localized risks depending on sourcing geography. Imported materials are less likely to carry biosolid-associated PFAS, but packaging and processing exposure remains possible.

Tier your ingredients by physical characteristics. Root botanicals, leaf powders, and liquid extracts tend to accumulate PFAS at higher concentrations than seed or bark materials. High-moisture and high-surface-area materials are your first priority for baseline testing.

Set a supplier data request standard. For high-priority ingredients, request PFAS panel results from your supplier covering at least the last three manufacturing lots. If the supplier can’t produce that data, that’s a meaningful signal about the maturity of their QA program — one worth factoring into your vendor risk rating.

Commission baseline independent testing. For your highest-risk ingredients, run at least one full PFAS panel through an ISO 17025-accredited analytical testing laboratory that you’ve qualified independently of your supplier. Not as a one-time exercise, but as part of your incoming material specification. Document the method, the lab’s accreditation scope, and your action thresholds (even if your initial threshold is “report results pending risk review” — that’s still more defensible than nothing).

Update your raw material specifications. Add a PFAS section to your spec sheets. Include the target panel, the testing frequency for each ingredient tier, and your action levels. The act of incorporating PFAS into your formal specifications demonstrates due diligence, creates an audit trail, and gives you longitudinal data to set evidence-based acceptance criteria over time.

What’s Coming

FDA’s PFAS Strategic Plan explicitly names dietary supplements as a category of ongoing surveillance interest. The agency has been steadily expanding its food PFAS monitoring, and supplement-specific guidance has been signaled as forthcoming. EFSA’s 4.4 ng/kg/week benchmark will almost certainly inform whatever action levels FDA proposes, just as EFSA’s earlier positions shaped FDA thinking on heavy metals.

The brands that are ahead of this aren’t waiting for a final rule. They’re building testing histories now, qualifying analytical testing laboratories, and writing PFAS into their incoming QC specifications while the regulatory window is still open. By the time formal FDA limits arrive, those brands will have clean data and a functioning program. Everyone else will be scrambling to retrofit one under pressure.

For Midwest supplement companies sourcing domestic botanicals — from farmland in Illinois, Indiana, or Wisconsin that has decades of biosolid application history — this is an active supply chain risk, not a future hypothetical. Treat it that way.

Our Chicago receiving facility accepts incoming raw material samples for PFAS panel screening as part of comprehensive incoming QC programs, with testing performed at our ISO 17025-accredited California laboratory. Standard PFAS panels (40 compounds, LC-MS/MS) typically return results within 7–10 business days from receipt.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Related from our network

• Supplement raw material testing under ISO 17025 accreditation — Qalitex Laboratories offers full-panel incoming QC testing including heavy metals (ICP-MS), botanical identity (HPTLC + DNA barcoding), microbiology, and emerging contaminant screening from their California-accredited facility.